Table 2.
Effect likelihood ratio tests cancer stage, nodal stage (N stage), baseline CTC number (log 2 transformed + 1) to predict recurrence and death
| Recurrence | Adjusting for tumour stage | Mortality | Adjusting for tumour stage | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Term | DF | L-R ChiSquare | Prob > ChiSq | Term | DF | L-R ChiSquare | Prob > ChiSq | ||
| Tumour Stage | 3 | 10.07 | 0.018* | Tumour Stage | 3 | 13.91 | 0.0030* | ||
| Log2[CTC number baseline + 1] | 1 | 4.23 | 0.040* | Log2[CTC number baseline + 1] | 1 | 6.2 | 0.013* | ||
| Adjusting for nodal stage | Adjusting for nodal stage | ||||||||
| Term | DF | L-R ChiSquare | Prob > ChiSq | Term | DF | L-R ChiSquare | Prob > ChiSq | ||
| Nodal Stage | 3 | 5.45 | 0.14 | Nodal Stage | 3 | 3.73 | 0.29 | ||
| Log2[CTC number baseline + 1] | 1 | 4.01 | 0.045* | Log2[CTC number baseline + 1] | 1 | 6.34 | 0.019* | ||